Sana Biotechnology (SANA) Non Operating Income (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Non Operating Income data on file, last reported at $951000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 4.13% year-over-year to $951000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 54.83% YoY), and the FY2025 full-year result was $3.8 million, down 63.25% from the prior year.
• Non Operating Income slipped to $951000.0 in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.2 million in Q2 2024 to a low of $339000.0 in Q1 2022.
• A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income jumped 642.41% in 2022 and plunged 81.98% in 2025, its largest moves.
• Tracing SANA's Non Operating Income over 5 years: stood at $1.6 million in 2022, then soared by 69.0% to $2.7 million in 2023, then slumped by 39.25% to $1.7 million in 2024, then decreased by 22.95% to $1.3 million in 2025, then retreated by 25.47% to $951000.0 in 2026.
• Business Quant data shows SANA's Non Operating Income at $951000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.0 million in Q3 2025.